GeoVax Labs, Inc.
GOVX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | -0.01 | 0.07 | -0.01 |
| FCF Yield | -192.76% | -183.22% | -79.85% | -8.15% |
| EV / EBITDA | -0.29 | -0.27 | 0.26 | -6.83 |
| Quality | ||||
| ROIC | -498.05% | -464.02% | -52.71% | -294.06% |
| Gross Margin | 97.59% | 0.00% | 30.51% | -3,940.04% |
| Cash Conversion Ratio | 0.99 | 0.97 | 1.36 | 0.60 |
| Growth | ||||
| Revenue 3-Year CAGR | 264.70% | -100.00% | -64.51% | -31.05% |
| Free Cash Flow Growth | 2.09% | -31.61% | -70.44% | -286.75% |
| Safety | ||||
| Net Debt / EBITDA | 0.22 | 0.24 | 1.98 | 0.62 |
| Interest Coverage | -1,176.34 | 0.00 | 0.00 | -14,576.98 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | -317.39 |
| Cash Conversion Cycle | -7,018.69 | -49.37 | -11,333.66 | -2.97 |